1. Microbiology and Infectious Disease
  2. Structural Biology and Molecular Biophysics
Download icon

Ebola and Marburg virus matrix layers are locally ordered assemblies of VP40 dimers

  1. William Wan
  2. Mairi Clarke
  3. Michael J Norris
  4. Larissa Kolesnikova
  5. Alexander Koehler
  6. Zachary A Bornholdt
  7. Stephan Becker
  8. Erica Ollman-Saphire
  9. John AG Briggs  Is a corresponding author
  1. Vanderbilt University, United States
  2. EMBL, Germany
  3. La Jolla Institute of Immunology, United States
  4. Philipps-Universität Marburg, Germany
  5. Scripps Research Institute, United States
  6. La Jolla Institute for Immunology, United States
  7. MRC-LMB, United Kingdom
Research Article
  • Cited 0
  • Views 542
  • Annotations
Cite this article as: eLife 2020;9:e59225 doi: 10.7554/eLife.59225

Abstract

Filoviruses such as Ebola and Marburg virus bud from the host membrane as enveloped virions. This process is achieved by the matrix protein VP40. When expressed alone, VP40 induces budding of filamentous virus-like particles, suggesting that localization to the plasma membrane, oligomerization into a matrix layer, and generation of membrane curvature are intrinsic properties of VP40. There has been no direct information on the structure of VP40 matrix layers within viruses or virus-like particles. We present structures of Ebola and Marburg VP40 matrix layers in intact virus-like particles, and within intact Marburg viruses. VP40 dimers assemble extended chains via C-terminal domain interactions. These chains stack to form 2D matrix lattices below the membrane surface. These lattices form a patchwork assembly across the membrane and suggesting that assembly may begin at multiple points. Our observations define the structure and arrangement of the matrix protein layer that mediates formation of filovirus particles.

Article and author information

Author details

  1. William Wan

    Department of Biochemistry, Vanderbilt University, Nashville, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2497-3010
  2. Mairi Clarke

    Structural and Computational Biology, EMBL, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9658-4308
  3. Michael J Norris

    La Jolla Institute of Immunology, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Larissa Kolesnikova

    Institute of Virology; German Center for Infection Research (DZIF) Gießen-Marburg-Langen Site, Philipps-Universität Marburg, Marburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Alexander Koehler

    Institute of Virology; German Center for Infection Research (DZIF) Gießen-Marburg-Langen Site, Philipps-Universität Marburg, Marburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Zachary A Bornholdt

    Scripps Research Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7557-9219
  7. Stephan Becker

    Institute of Virology; German Center for Infection Research (DZIF) Gießen-Marburg-Langen Site, Philipps-Universität Marburg, Marburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Erica Ollman-Saphire

    Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. John AG Briggs

    Structural Studies, MRC-LMB, Cambridge, United Kingdom
    For correspondence
    jbriggs@mrc-lmb.cam.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3990-6910

Funding

Medical Research Council (MC_UP_1201/16)

  • John AG Briggs

H2020 European Research Council (ERC-CoG-648432)

  • John AG Briggs

Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 1021)

  • Stephan Becker

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Wesley I Sundquist, University of Utah School of Medicine, United States

Publication history

  1. Received: May 22, 2020
  2. Accepted: October 2, 2020
  3. Accepted Manuscript published: October 5, 2020 (version 1)

Copyright

© 2020, Wan et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 542
    Page views
  • 116
    Downloads
  • 0
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading

    1. Immunology and Inflammation
    2. Microbiology and Infectious Disease
    Patrick S Mitchell et al.
    Research Article

    Bacteria of the genus Shigella cause shigellosis, a severe gastrointestinal disease that is a major cause of diarrhea-associated mortality in humans. Mice are highly resistant to Shigella and the lack of a tractable physiological model of shigellosis has impeded our understanding of this important human disease. Here we propose that the differential susceptibility of mice and humans to Shigella is due to mouse-specific activation of the NAIP–NLRC4 inflammasome. We find that NAIP–NLRC4-deficient mice are highly susceptible to oral Shigella infection and recapitulate the clinical features of human shigellosis. Although inflammasomes are generally thought to promote Shigella pathogenesis, we instead demonstrate that intestinal epithelial cell (IEC)-specific NAIP–NLRC4 activity is sufficient to protect mice from shigellosis. In addition to describing a new mouse model of shigellosis, our results suggest that the lack of an inflammasome response in IECs may help explain the susceptibility of humans to shigellosis.

    1. Microbiology and Infectious Disease
    Jun Kurushima et al.
    Research Article Updated

    The spread of antimicrobial resistance and vaccine escape in the human pathogen Streptococcus pneumoniae can be largely attributed to competence-induced transformation. Here, we studied this process at the single-cell level. We show that within isogenic populations, all cells become naturally competent and bind exogenous DNA. We find that transformation is highly efficient and that the chromosomal location of the integration site or whether the transformed gene is encoded on the leading or lagging strand has limited influence on recombination efficiency. Indeed, we have observed multiple recombination events in single recipients in real-time. However, because of saturation and because a single-stranded donor DNA replaces the original allele, transformation efficiency has an upper threshold of approximately 50% of the population. The fixed mechanism of transformation results in a fail-safe strategy for the population as half of the population generally keeps an intact copy of the original genome.